Marta Garrote

25PUBLICATIONS
133CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Jun 04, 2026
Cesni-cel (ARI0002h) in ultra-high-risk multiple myeloma with plasma cell leukaemia or central nervous system involvement.

|Mar 03, 2026
Enhanced antitumoral activity of the academic CAR-T ARI0002h against normal and low BCMA-expressing myeloma cells after incorporating a transmembrane CD28 domain.

Oriol Cardus, Joan Mañé Pujol, Anna de Daniel

|Jul 11, 2025
Microbiota Shape Metabolic and Immune Determinants of CAR-T Therapy and Correlate with Outcomes in Myeloma.

Mireia Uribe-Herranz, Aina Oliver-Caldés, Neus Martínez-Micaelo

|Jun 27, 2025
Bicistronic CAR T Cell against BCMA and CD229 Effectively Controls Myeloma Even When BCMA Expression Is Limited.

Luis Gerardo Rodríguez-Lobato, Oriol Cardús, Joan Mañé-Pujol

|Dec 06, 2024
Genetic disruption of Blimp-1 drastically augments the antitumor efficacy of BCMA-targeting CAR T cells.

Anthony M Battram, Joan Mañé-Pujol, David F Moreno

|Dec 05, 2024
Bispecific antibodies targeting BCMA or GPRC5D are highly effective in relapsed myeloma after CAR T-cell therapy.

Maximilian Merz, Danai Dima, Hamza Hashmi

Pageof 5

Frequent Collaborators

19 joint publications

Carlos Fernández de Larrea

11 joint publications

Luis-Gerardo Rodríguez-Lobato

9 joint publications

Laura Rosiñol

8 joint publications

David F Moreno